Colon and Rectal Cancer

• Screen-Detected Colon Cancer Postoperative Outcomes ‘Better’
• TAILOR Supports Cetuximab–FOLFOX-4 For RAS Wild-Type Metastatic Colorectal Cancer
• Standard of care in pre-op radiation of rectal cancer
• Adjuvant treatment
• Metastatic disease
• ESMO Academy 2018
• Laparoscopy For CRC Liver Metastases Surgery Increasingly Feasible
• Complementary Medicine Use Linked to Conventional Cancer Treatment Refusal
• Metastatic CRC Survival Boosted With Fruquintinib In Chinese Patients
• Can we refine the selection for adjuvant treatment in stage III colon cancer?
• Can we refine the selection for adjuvant treatment in stage II colon cancer?
• Discussion of abstracts: O-025, O-026, O-027
• The left versus right colon cancer story: What is the truth?
• Explaining the unexplainable: CALGB vs FIRE-3 discrepant data
• Selecting the optimal first-line treatment in advanced colorectal cancer: Discussion of abstracts O-022 to O-024
• Is broad NGS testing useful in patients with metastatic colorectal cancer? - Pro
• Evolution and innovations in rectal cancer surgery
• Rectal cancer after neoadjuvant therapy with complete clinical response - Watchful waiting
• Rectal cancer after neoadjuvant therapy with complete clinical response - Surgery
• Debate: This house believes multiparametric MRI is the holy grail for organ preservation inrectal cancer - Against the motion
• Late treatment lines in colorectal cancer: any progress?
• Systemic treatment of advanced colorectal cancer
• Adjuvant-neoadjuvant systemic treatment of colorectal cancer
• ASCO 2018: PRODIGE 7 Rules Out Oxaliplatin HIPEC For Colorectal Peritoneal Carcinomatosis
• ESMO Preceptorship on Colorectal Cancer Valencia May 2018

• « Previous
• 1
• 2
• ...
• 71
• Next »